Although the expression of ASCL2 is negatively correlated with IFN-γ and IFN-α response pathways in several cancer types, COAD MSS samples have the highest expression of ASCL2 among these cancer types (Figure 5(c)). This evidence concerns the gene ASCL2 and cancer.